Stay updated with breaking news from Therapeutic Development Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report published on Sunday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance NAVB opened at $0.11 on Friday. The firm has a market cap of $11.38 million, a PE ratio of -0.39 and a beta of […]
StockNews.com initiated coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report report published on Saturday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Trading Up 23.4 % Shares of NAVB opened at $0.10 on Friday. Navidea Biopharmaceuticals has a 12 month low of $0.06 and a 12 […]
StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report released on Friday. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance NYSE NAVB opened at $0.08 on Friday. Navidea Biopharmaceuticals has a 1 year low of $0.06 and a 1 year high of $0.39. The […]
StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report report published on Wednesday morning. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance NAVB opened at $0.08 on Wednesday. The company’s 50 day simple moving average is $0.09 and its two-hundred day simple moving […]
StockNews.com initiated coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report issued on Tuesday morning. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance Shares of NYSE:NAVB opened at $0.07 on Tuesday. Navidea Biopharmaceuticals has a twelve month low of $0.07 and a twelve month high of […]